Instil Bio Inc (TIL): im back out, lol. was worth a try.

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	1057
Posts	131799
Boards Moderated	1
Alias Born	03/07/2007

gail

Re: gail post# 20

Wednesday, 12/28/2022 10:50:25 AM

Wednesday, December 28, 2022 10:50:25 AM

im back out, lol. was worth a try.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent TIL News

Instil Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/21/2024 09:00:58 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:08:17 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 10:36:52 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 12:01:42 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 10:00:34 PM
Instil Bio Announces Strategic Update • GlobeNewswire Inc. • 01/16/2024 01:00:27 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 01:10:49 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 12:49:04 AM
Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 10:00:31 PM
Instil Bio Announces Effective Date of 1-for-20 Reverse Stock Split • GlobeNewswire Inc. • 12/05/2023 10:00:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 12:13:52 PM
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 11/13/2023 10:27:05 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 10:03:23 PM
Instil Bio Reports Third Quarter 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/13/2023 10:00:57 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 10:00:35 PM
Instil Bio Announces Poster Presentations of ITIL-306 Preclinical Data at SITC 2023 Annual Meeting • GlobeNewswire Inc. • 11/06/2023 12:00:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 11:05:14 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 11:01:00 AM
Instil Bio Reports Second Quarter 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/14/2023 11:00:15 AM
Instil Bio Announces Oral Presentation of ITIL-306 Preclinical Data at British Society for Gene and Cell Therapy Annual Conference • GlobeNewswire Inc. • 06/26/2023 08:38:04 PM
Instil Bio Reports First Quarter 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/11/2023 11:00:00 AM

More TIL News

InvestorsHub NewsWire

FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover